| 1. |
New Options Granted:
|
|
Position
|
||||||
|
(Director/
|
||||||
|
Officer/
|
No. of
|
|||||
|
Employee/
|
Options
|
|||||
|
Consultant/
|
Insider
|
No. of
|
Granted in
|
|||
|
Management
|
Yes or
|
Optioned
|
Exercise
|
Expiry
|
Past 12
|
|
|
Name of Optionee
|
Company
|
No?
|
Shares
|
Price
|
Date
|
Months
|
|
Employees and/or Consultants of the Issuer
|
Employees
|
No
|
13,500
|
$0.60
|
September 19, 2027
|
65,000
|
|
Employees and/or Consultants of a Subsidiary
|
Employees
|
No
|
11,500
|
$0.60
|
September 19, 2027
|
23,500
|
|
Directors and/or Officers of the Issuer
|
Directors
|
Yes
|
180,000
|
$0.60
|
September 19, 2027
|
50,000
|
| 2. |
Other Presently Outstanding Options:
|
|
Name of Optionee
|
No. of Optioned
Shares(1)
|
Exercise
Price
|
Original Date of
Grant
|
Expiry Date
|
|
Employees and/or Consultants of the Issuer
|
18,500
|
$1.21
|
June 6, 2022
|
June 6, 2027
|
|
Employees and/or Consultants of a Subsidiary
|
10,000
|
$1.21
|
June 6, 2022
|
June 6, 2027
|
|
Employees and/or Consultants of the Issuer
|
9,000
|
$2.73
|
April 4, 2022
|
April 4, 2027
|
|
Employees and/or Consultants of a Subsidiary
|
10,000
|
$2.73
|
April 4, 2022
|
April 4, 2027
|
|
Directors and/or Officers of the Issuer
|
50,000
|
$2.73
|
April 4, 2022
|
April 4, 2027
|
|
Employees and/or Consultants of the Issuer
|
5,000
|
$4.62
|
December 27, 2021
|
December 27, 2026
|
|
Employees and/or Consultants of a Subsidiary
|
3,500
|
$4.62
|
December 27, 2021
|
December 27, 2026
|
|
Employees and/or Consultants of the Issuer
|
10,166
|
$4.50
|
September 27, 2021
|
September 27, 2026
|
|
Employees and/or Consultants of a Subsidiary
|
3,300
|
$34.55
|
July 9, 2021
|
September 27, 2022
|
|
Directors and Officers of the Issuer
|
1,168,715
|
$5.87
|
May 19, 2021
|
May 19, 2026
|
|
Employees and Consultants of the Issuer
|
232,166
|
$5.87
|
May 19, 2021
|
May 19, 2026
|
|
Directors and/or Officers of a Subsidiary
|
520,000
|
$10.02
|
March 18, 2021
|
March 18, 2026
|
|
Employees and/or Consultants of a Subsidiary
|
155,000
|
$10.02
|
March 18, 2021
|
March 18, 2026
|
|
Directors and/or Officers of the Issuer
|
180,000
|
$10.00
|
February 28, 2021
|
February 28, 2026
|
|
Employees and/or Consultants of the Issuer
|
5,500
|
$10.00
|
February 8, 2021
|
February 8, 2026
|
|
Employees and/or Consultants of the Issuer
|
10,000
|
$8.56
|
December 15, 2020
|
December 15, 2025
|
|
Employees and/or Consultants of a Subsidiary
|
25,000
|
$7.12
|
October 23, 2020
|
October 23, 2025
|
|
Employees and/or Consultants of the Issuer
|
3,750
|
$7.12
|
October 23, 2020
|
October 23, 2025
|
|
Employees and/or Consultants of the Issuer
|
13,750
|
$5.80
|
July 17, 2020
|
July 17, 2025
|
|
Employees and/or Consultants of the Issuer
|
187,500
|
$4.00
|
June 9, 2020
|
June 9, 2025
|
|
Employees and/or Consultants of a Subsidiary
|
31,250
|
$4.00
|
June 9, 2020
|
June 9, 2025
|
|
Directors and/or Officers of the Issuer
|
190,000
|
$4.00
|
June 9, 2020
|
June 9, 2025
|
|
Employees and/or Consultants of the Issuer
|
141,225
|
$1.60
|
October 11, 2019
|
January 4, 2029
|
|
Directors and/or Officers of the Issuer
|
550,000
|
$1.60
|
October 11, 2019
|
January 4, 2029
|
|
Employees and/or Consultants of the Issuer
|
100,000
|
$1.60
|
October 11, 2019
|
September 11, 2029
|
|
Directors and/or Officers of the Issuer
|
675,000
|
$1.60
|
October 11, 2019
|
September 11, 2029
|
|
Directors and/or Officers of the Issuer
|
62,500
|
$1.60
|
October 11, 2019
|
April 7, 2029
|
|
Employees and/or Consultants of the Issuer
|
2,500
|
$1.60
|
October 11, 2019
|
May 13, 2029
|
|
Employees and/or Consultants of the Issuer
|
55,000
|
$1.60
|
October 11, 2019
|
August 11, 2029
|
|
Directors and/or Officers of a Subsidiary
|
37,500
|
$1.60
|
October 11, 2019
|
July 30, 2029
|
|
Employees and/or Consultants of the Issuer
|
4,000
|
$4.20
|
October 11, 2019
|
October 9, 2022
|
| 3. |
Additional Information
|
| (a) |
If shareholder approval was required for the grant of options (including prior approval of a stock option plan), state the date that the shareholder meeting approving the grant was or will be held. July
28, 2021
|
| (b) |
State the date of the news release announcing the grant of options. N/A
|
| (c) |
State the total issued and outstanding share capital at the date of grant or amendment 74,582,821 common shares
|
| (d) |
State, as a percentage of the issued and outstanding shares of the Issuer indicated in (c) above, the aggregate number of shares that are subject to incentive stock options, including new options, amended options and other presently
outstanding options. 6.26%
|
| (e) |
If the new options are being granted pursuant to a stock option plan, state the number of remaining shares reserved for issuance under the plan. 2,783,460
|
| (f) |
If the Issuer has completed a public distribution of its securities within 90 days of the date of grant, state the per share price paid by the public investors. N/A
|
| (g) |
Describe the particulars of any proposed material changes in the affairs of the Issuer. N/A
|
| 4. |
Certificate of Compliance
|
| 1. |
The undersigned is a director and/or senior officer of the Issuer and has been duly authorized by a resolution of the board of directors of the Issuer to sign this Certificate of Compliance.
|
| 2. |
As of the date hereof there is no material information concerning the Issuer which has not been publicly disclosed.
|
| 3. |
The undersigned hereby certifies to the Exchange that the Issuer is in compliance with the requirements of applicable securities legislation (as such term is defined in National Instrument 14-101) and all Exchange Requirements (as
defined in CNSX Policy 1).
|
| 4. |
All of the information in this Form 11 Notice of Proposed Stock Option Grant or Amendment is true.
|
|
|
Oren Shuster
Name of Director or Senior Officer
“Oren Shuster”
Signature
Chief Executive Officer
Official Capacity
|